Biblio

Found 23 results

Author Keyword Title Type [ Year

]

Filters: Author is Nicoletta Colombo [Clear All Filters]

2016

P. Harter, Johnson, T., Berton-Rigaud, D., Park, S. - Y., Friedlander, M. Leonard, Del Campo, J. M., Shimada, M., Forget, F., Mirza, M. R., Colombo, N., Zamagni, C., Chan, J. K., Imhof, M., Herzog, T. J., O'Donnell, D., Heitz, F., King, K., Stinnett, S., Barrett, C., Jobanputra, M., Xu, C. - F., and du Bois, A., “BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.”, Gynecol Oncol, vol. 140, no. 3, pp. 443-9, 2016.

A. du Bois, Kristensen, G. B., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I. B., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G., Meier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. Oliver, Merger, M., and Harter, P., “Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.”, Lancet Oncol, vol. 17, no. 1, p. 89, 2016.

2015

A. Floquet, Vergote, I. B., Colombo, N., Fiane, B., Monk, B. J., Reinthaller, A., Calvert, P., Herzog, T. J., Meier, W., Kim, J. - W., Del Campo, J. M., Friedlander, M. Leonard, Pisano, C., Isonishi, S., Crescenzo, R. J., Barrett, C., Wang, K., Mitrica, I., and du Bois, A., “Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.”, Gynecol Oncol, vol. 136, no. 1, p. 42, 2015.

2014

I. Ray-Coquard, Brown, J., Harter, P., Provencher, D. M., Fong, P. C., Maenpaa, J. U., Ledermann, J. A., Emons, G., Rigaud, D. Berton, Glasspool, R. M., Mezzanzanica, D., and Colombo, N., “Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors.”, Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S42-7, 2014.

A. du Bois, Floquet, A., Kim, J. - W., Rau, J., Del Campo, J. M., Friedlander, M. Leonard, Pignata, S., Fujiwara, K., Vergote, I. B., Colombo, N., Mirza, M. R., Monk, B. J., Kimmig, R., Ray-Coquard, I., Zang, R., Diaz-Padilla, I., Baumann, K. H., Mouret-Reynier, M. - A., Kim, J. - H., Kurzeder, C., Lesoin, A., Vasey, P. A., Marth, C., Canzler, U., Scambia, G., Shimada, M., Calvert, P., Pujade-Lauraine, E., Kim, B. - G., Herzog, T. J., Mitrica, I., Schade-Brittinger, C., Wang, Q., Crescenzo, R. J., and Harter, P., “Incorporation of pazopanib in maintenance therapy of ovarian cancer.”, J Clin Oncol, vol. 32, no. 30, p. 3382, 2014.

F. Collinson, Qian, W., Fossati, R., Lissoni, A., Williams, C., Parmar, M. K. B., Ledermann, J. A., Colombo, N., and Swart, A. Marie, “Optimal treatment of early-stage ovarian cancer.”, Ann Oncol, vol. 25, no. 6, pp. 1165-71, 2014.

I. B. Vergote, Jimeno, A., Joly, F., Katsaros, D., Coens, C., Despierre, E., Marth, C., Hall, M., Steer, C. B., Colombo, N., Lesoin, A., Casado, A., Reinthaller, A., Green, J. A., Buck, M., Ray-Coquard, I., Ferrero, A., Favier, L., Reed, N. Simon, Curé, H., and Pujade-Lauraine, E., “Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a EORTC GCG, and GCIG study.”, J Clin Oncol, vol. 32, no. 4, pp. 320-6, 2014.

2013

F. A. Raja, Counsell, N., Colombo, N., Pfisterer, J., du Bois, A., Parmar, M. K. B., Vergote, I. B., Gonzalez-Martin, A., Alberts, D. S., Plante, M., Torri, V., and Ledermann, J. A., “Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.”, Ann Oncol, vol. 24, no. 12, pp. 3028-34, 2013.

2011

T. Thigpen, du Bois, A., McAlpine, J., DiSaia, P., Fujiwara, K., Hoskins, W. J., Kristensen, G. B., Mannel, R., Markman, M., Pfisterer, J., Quinn, M., Reed, N. Simon, Swart, A. Marie, Berek, J. S., Colombo, N., Freyer, G., Gallardo, D., Plante, M., Poveda, A. M., Rubinstein, L., Bacon, M., Kitchener, H. C., and Stuart, G. C. E., “First-line therapy in ovarian cancer trials.”, Int J Gynecol Cancer, vol. 21, no. 4, pp. 756-62, 2011.

2010

E. L. Trimble, Birrer, M. J., Hoskins, W. J., Marth, C., Petryshyn, R., Quinn, M., Thomas, G. M., Kitchener, H. C., Aghajanian, C., Alberts, D. S., Armstrong, D., Brown, J., Coleman, R. L., Colombo, N., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Hunsberger, S., Kaye, S. B., Ledermann, J. A., Lee, S., Look, K., Mannel, R., McNeish, I. A., Minasian, L. M., Oza, A. M., Paul, J., Poveda, A. M., Pujade-Lauraine, E., Schoenfeldt, M., Swart, A. Marie, von Gruenigen, V., and Wenzel, L. B., “Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009.”, Int J Gynecol Cancer, vol. 20, no. 7, pp. 1290-8, 2010.

S. Pecorelli, Ray-Coquard, I., Tredan, O., Colombo, N., Parma, G., Tisi, G., Katsaros, D., Lhommé, C., Lissoni, A., Vermorken, J. B., du Bois, A., Poveda, A. M., Frigerio, L., Barbieri, P., Carminati, P., Brienza, S., and Guastalla, J. P., “Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.”, Ann Oncol, vol. 21, no. 4, pp. 759-65, 2010.

H. Mackay, Brady, M. F., Oza, A. M., Reuss, A., Pujade-Lauraine, E., Swart, A. Marie, Siddiqui, N. Ahmad, Colombo, N., Bookman, M. A., Pfisterer, J., du Bois, A., and InterGroup, G. Cancer, “Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer”, Int J Gynecol Cancer, vol. 20, pp. 945-52, 2010.

2009

M. A. Bookman, Brady, M. F., McGuire, W. P., Harper, P. G., Alberts, D. S., Friedlander, M. Leonard, Colombo, N., Fowler, J. M., Argenta, P. A., De Geest, K., Mutch, D. G., Burger, R. A., Swart, A. Marie, Trimble, E. L., Accario-Winslow, C., and Roth, L. M., “Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.”, J Clin Oncol, vol. 27, no. 9, pp. 1419-25, 2009.

2005

A. Buda, Fossati, R., Colombo, N., Fei, F., Floriani, I., D. Alletti, G., Katsaros, D., Landoni, F., Lissoni, A., Malzoni, C., Schröder, W., Scollo, P., Torri, V., Zola, P., and Mangioni, C., “Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Por”, J Clin Oncol, vol. 23, pp. 4137-45, 2005.

2003

N. Colombo, Guthrie, D., Chiari, S., Parmar, M. K. B., Qian, W., Swart, A. Marie, Torri, V., Williams, C., Lissoni, A., Bonazzi, C., and Collaborators, I. Collaborat, “International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer”, J Natl Cancer Inst, vol. 95, pp. 125-32, 2003.

N. Colombo, Guthrie, D., Chiari, S., Parmar, M. K. B., Qian, W., Swart, A. Marie, Torri, V., Williams, C., Lissoni, A., and Bonazzi, C., “International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer.”, J Natl Cancer Inst, vol. 95, no. 2, pp. 125-32, 2003.

J. B. Trimbos, Parmar, M. K. B., Vergote, I. B., Guthrie, D., Bolis, G., Colombo, N., Vermorken, J. B., Torri, V., Mangioni, C., Pecorelli, S., Lissoni, A., Swart, A. Marie, Neoplasm, I. Collaborat, Research, E. Organisati, and Neoplasm, Tof Cancer, “International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma”, J Natl Cancer Inst, vol. 95, pp. 105-12, 2003.

M. K. B. Parmar, Ledermann, J. A., Colombo, N., du Bois, A., Delaloye, J. F., Kristensen, G. B., Wheeler, S., Swart, A. Marie, Qian, W., Torri, V., Floriani, I., Jayson, G. C., Lamont, A., Tropé, C. G., ,, and Collaborators, A. G. O., “Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial”, Lancet, vol. 361, pp. 2099-106, 2003.

M. K. B. Parmar, Ledermann, J. A., Colombo, N., du Bois, A., Delaloye, J. - F., Kristensen, G. B., Wheeler, S., Swart, A. Marie, Qian, W., Torri, V., Floriani, I., Jayson, G. C., Lamont, A., and Tropé, C. G., “Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.”, Lancet, vol. 361, no. 9375, pp. 2099-106, 2003.

2000

N. Colombo, Parma, G., Bocciolone, L., Franchi, D., Sideri, M., and Maggioni, A., “Medical therapy of advanced malignant epithelial tumours of the ovary”, Forum (Genova), vol. 10, pp. 323-32, 2000.

1995

M. E. L. van der Burg, van Lent, M., Buyse, M., Kobierska, A., Colombo, N., Favalli, G., Lacave, A. J., Nardi, M., Renard, J., and Pecorelli, S., “The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer”, N Engl J Med, vol. 332, pp. 629-34, 1995.

1994

E. Eisenhauer, Huinink, W. W. ten Bok, Swenerton, K. D., Gianni, L., Myles, J., van der Burg, M. E. L., Kerr, I., Vermorken, J. B., Buser, K., and Colombo, N., “European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion”, J Clin Oncol, vol. 12, pp. 2654-66, 1994.

E. Eisenhauer, Huinink, W. W. ten Bok, Swenerton, K. D., Gianni, L., Myles, J., van der Burg, M. E. L., Kerr, I., Vermorken, J. B., Buser, K., and Colombo, N., “European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.”, J Clin Oncol, vol. 12, no. 12, pp. 2654-66, 1994.